Filing Details

Accession Number:
0001567619-20-016247
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-01 17:31:50
Reporting Period:
2020-09-01
Accepted Time:
2020-09-01 17:31:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1724344 Entasis Therapeutics Holdings Inc. ETTX Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1080014 Innoviva, Inc. 1350 Old Bayshore Highway Suite 400
Burlingame CA 94010
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-01 4,672,897 $2.68 18,672,897 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to Purchase Common Stock Acquisiton 2020-09-01 4,672,897 $2.68 4,672,897 $2.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,672,897 2020-09-01 2025-09-01 No 4 P Direct
Footnotes
  1. See Exhibit 99.1